Literature DB >> 19828095

Nasal-sinus polyposis: clinical-cytological grading and prognostic index of relapse.

M Gelardi1, R Fiorella, M L Fiorella, C Russo, P Soleti, G Ciprandi.   

Abstract

This longitudinal and prospective study aimed at investigating the influence of some parameters,including nasal cytology and clinical findings (such as asthma, atopy, acetylsalicylic acid (ASA) sensitivity, ASA associated with asthma), as risk factor of post-surgical relapse of nasal-sinus polyps. One hundred sixty-one consecutive patients (92 males and 69 females, mean age 47 years), affected by bilateral nasal polyposis and who had undergone surgical nasal polypectomy (endoscopic FESS), were examined post-surgically at least every 6 months for a period of 10 years. Endoscopic exam and nasal cytology exam were carried out on all patients and their case histories were carefully examined. The association eosinophilic-mast cell cellularity and the contemporary presence of asthma + ASA sensitivity showed the highest level of relapse (OR 4.5). In conclusion, cytological data in association with certain clinical parameters can predict a high risk prognosis of relapse.

Entities:  

Mesh:

Year:  2009        PMID: 19828095

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  8 in total

1.  Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment.

Authors:  M Gelardi; F Barbara; I Covelli; M A Damiani; F Plantone; A Notarnicola; B Moretti; N Quaranta; G Ciprandi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-01

2.  A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis.

Authors:  Giuseppe Brescia; Gino Marioni; Sebastiano Franchella; Giulia Ramacciotti; Luciano Giacomelli; Filippo Marino; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-13       Impact factor: 2.503

3.  Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps.

Authors:  Karolina Dzaman; Miroslaw J Szczepanski; Marta Molinska-Glura; Antoni Krzeski; Mariola Zagor
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-12-12       Impact factor: 4.291

4.  The relevance of counseling in patients with nasal polyps.

Authors:  M Gelardi; N De Candia; N Quaranta; C Russo; P Pecoraro; M Mancini; P Luperto; G Lombardo; A Macchi; C Bocciolini; A Ciofalo; E De Corso; G Ciprandi
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

5.  Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach.

Authors:  M Gelardi; L Iannuzzi; M De Giosa; S Taliente; N De Candia; N Quaranta; E De Corso; V Seccia; G Ciprandi
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-02       Impact factor: 2.124

6.  Nasal Cytology: A Comparative Study of Two Different Techniques of Processing-Smeared versus Cytocentrifuged Slides.

Authors:  Maria Laura Bartoli; Lodovica Cristofani-Mencacci; Mariella Scarano; Andrea Nacci; Manuela Latorre; Elena Bacci; Pierluigi Paggiaro; Veronica Seccia
Journal:  Mediators Inflamm       Date:  2018-11-14       Impact factor: 4.711

7.  Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity.

Authors:  M Gelardi; K Piccininni; N Quaranta; V Quaranta; M Silvestri; G Ciprandi
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-10       Impact factor: 2.124

8.  Exploring the role of nasal cytology in chronic rhinosinusitis.

Authors:  Stefania Gallo; Francesco Bandi; Andrea Preti; Carla Facco; Giorgia Ottini; Federica Di Candia; Francesco Mozzanica; Laura Saderi; Fausto Sessa; Marcella Reguzzoni; Giovanni Sotgiu; Paolo Castelnuovo
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-10       Impact factor: 2.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.